FDA.reportPublic FDA data

SODIUM CARBONATE

Substance profile for UNII 45P3261C7T, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for SODIUM CARBONATE
Structure render from PubChem CID 10340

Substance Identity#

UNII
45P3261C7T
Preferred term
SODIUM CARBONATE
Registry number
497-19-8
EC number
207-838-8
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
CO3.2Na
Chemical structure for SODIUM CARBONATE
Structure render from PubChem CID 10340

Chemical And Database Identifiers#

InChIKey
CDBYLPFSWZWCQE-UHFFFAOYSA-L
SMILES
[Na+].[Na+].[O-]C([O-])=O
RxCUI
36685
PubChem
10340
NCIt
C47721
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound10340https://pubchem.ncbi.nlm.nih.gov/compound/10340
PubChem InChIKey SearchCDBYLPFSWZWCQE-UHFFFAOYSA-Lhttps://pubchem.ncbi.nlm.nih.gov/#query=CDBYLPFSWZWCQE-UHFFFAOYSA-L
RxNorm36685https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=36685
NCI ThesaurusC47721https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47721
FDA Substance Registration System45P3261C7Thttps://precision.fda.gov/uniisearch/srs/unii/45P3261C7T
European Community number207-838-8https://commonchemistry.cas.org/results?q=207-838-8

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use ATORVASTATIN calcium tablets safely and effectively. See full prescribing information for ATORVASTATIN calcium tablets. ATORVASTATIN calcium tablets for oral administration Initial U.S. Approval: 19961
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE SODIUM2
Sodium CarbonateINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE SODIUM5
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TGoutFlex Gout Symptom Formula1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TDrug Facts1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TCeftazidime for Injection, USP12
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TCeftazidime for Injection, USP12
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TBJWC Nicotine Gum Drug Facts4
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TSuperValu Inc. Nicotine Gum Drug Facts4
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TKroger Co. Nicotine Polacrilex Gum 2 mg (nicotine) Drug Facts2
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TSuperValu Inc. Nicotine Gum Drug Facts4
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TKroger Co. Nicotine Polacrilex Gum 2 mg (nicotine) Drug Facts2
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TKroger Co. Nicotine Gum Drug Facts2
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TSupervalu Inc. Nicotine Gum Drug Facts4
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TMetformin Hydrochloride Extended-release Tablets, USP4
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use PANTOPRAZOLE sodium delayed-release tablets, USP safely and effectively. See full prescribing information for PANTOPRAZOLE sodium delayed-release tablets, USP. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral administration Initial U.S. approval: 200011
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TBJWC Nicotine Polacrilex Gum 2 mg (nicotine) Drug Facts4
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TDrug Facts1
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TDrug Facts1
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TGout Symptom Relief™1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. PANTOPRAZOLE sodium delayed-release tablets USP, for oral administration Initial U.S. approval: 20002
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE Sodium delayed-release tablets USP for oral use Initial U.S. approval: 20001
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TCVS Pharmacy, Inc. Nicotine Gum Drug Facts2
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TMetformin Hydrochloride Extended-release Tablets, USP4
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets USP safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets USP. PANTOPRAZOLE Sodium Delayed-Release Tablets USP for oral use Initial U.S. Approval: 20002
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TKroger Co. Nicotine Polacrilex Lozenge 4 mg (nicotine) Drug Facts2
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19962
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pantoprazole sodium safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 20001
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TGout Symptom Reliever1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 20001001
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPackage Labeling1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPackage Labeling1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TMcKesson Nicotine Polacrilex Gum USP, 2 mg (nicotine) Drug Facts2
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets. PANTOPRAZOLE SODIUM delayed-release tablets Initial U.S. approval: 20001
Sodium carbonateINACTIVE INGREDIENT45P3261C7TBayer ® Advanced Aspirin 325 mg Coated Tablet2
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets. PANTOPRAZOLE SODIUM delayed-release tablets Initial U.S. approval: 20003
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7T9b73e20a-4ac8-4111-a69e-17ee1bca8e651
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral use Initial U.S. Approval: 20001
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use ATORVASTATIN CALCIUM safely and effectively. See full prescribing information for ATORVASTATIN CALCIUM. ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM) TABLET, FILM COATED for ORAL use. Initial U.S. Approval: 20123
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use PANTOPRAZOLE SODIUM safely and effectively. See full prescribing information for PANTOPRAZOLE SODIUM. PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM) TABLET for ORAL use. Initial U.S. Approval: 20073
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TOverly-Sensitive™1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19964
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TClimate Adaptation Hot and Dry™1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pravastatin sodium safely and effectively. See full prescribing information for pravastatin sodium tablets. Initial U.S. Approval: 19911
Sodium carbonateINACTIVE INGREDIENT45P3261C7THandy Solutions GENUINE ASPIRIN BAYER1
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TMorale Remedy No. 191
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TAllergyEase Food and Chemical1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19963
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19961
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TDrug Facts1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use Meropenem for Injection safely and effectively. See full prescribing information for Meropenem for Injection. Meropenem for Injection Initial U.S. Approval: 1996 To reduce the development of drug-resistant bacteria and maintain the effectiveness of Meropenem for Injection and other antibacterial drugs, Meropenem for Injection should only be used to treat or prevent infections that are proven or strongly suspected to be caused by susceptible b17
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TCyclopentolate Hydrochloride Ophthalmic Solution USP, 1% (Sterile)2
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TSHISEIDO SUN PROTECTION FOUNDATION TRANSLUCENT1
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TAllergy Food and Chemical Relief1
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TAgoraFear Relief1
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TDRUG FACTS1
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7THomeopathic Tension Headache Formula1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TSHISEIDO SUN PROTECTION FOUNDATION1
Sodium CarbonateACTIVE INGREDIENT45P3261C7TCalm Remedy Water ®3
Sodium CarbonateACTIVE INGREDIENT45P3261C7TControl Remedy Water ®3
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TDrug Facts1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TDrug Facts1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TSHISEIDO THE MAKEUP STICK FOUNDATION Control Color1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TSHISEIDO THE MAKEUP STICK FOUNDATION1
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TAcid Detox3
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TAttention and Learning Enhancement3
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TGood Mood Enhancer1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 20002
Sodium CarbonateINACTIVE INGREDIENT45P3261C7T8a023942-01e8-4849-aa3c-1a640ffc7fd37
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
Sodium CarbonateACTIVE INGREDIENT45P3261C7TLymphatic Drainer2
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use PROTONIX safely and effectively. See full prescribing information for PROTONIX. PROTONIX (pantoprazole sodium) delayed-release tablets PROTONIX (pantoprazole sodium) for delayed-release oral suspension Initial U.S. approval: 20001
Sodium CarbonateACTIVE INGREDIENT45P3261C7TConnective Tissue5
Sodium CarbonateACTIVE INGREDIENT45P3261C7TEdema3
Sodium CarbonateACTIVE INGREDIENT45P3261C7TWarts - Moles - Skin Tags3
Sodium CarbonateACTIVE INGREDIENT45P3261C7TCandidiasis~Yeast2
Sodium CarbonateACTIVE INGREDIENT45P3261C7TLymphatic Drainer2
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TCold Sore Complex1
Sodium CarbonateACTIVE INGREDIENT45P3261C7TConnective Tissue1
Sodium CarbonateACTIVE INGREDIENT45P3261C7TEdema1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TMetformin Hydrochloride Extended - Release Tablets2
Sodium CarbonateACTIVE INGREDIENT45P3261C7TIndigestion - Gas2
Sodium CarbonateACTIVE INGREDIENT45P3261C7TIndigestion - Gas2
Sodium CarbonateACTIVE INGREDIENT45P3261C7TThroat Care2
Sodium CarbonateACTIVE INGREDIENT45P3261C7TThroat Care2
Sodium CarbonateACTIVE INGREDIENT45P3261C7TWarts - Moles - Skin Tags2
Sodium CarbonateACTIVE INGREDIENT45P3261C7TTummy Upset1
Sodium CarbonateACTIVE INGREDIENT45P3261C7TWarts - Moles - Skin Tags1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets, USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets, USP. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 20002
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 20001
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use PROTONIX safely and effectively. See full prescribing information for PROTONIX. PROTONIX (pantoprazole sodium) delayed-release tablets PROTONIX (pantoprazole sodium) for delayed-release oral suspension Initial U.S. approval: 20001
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TStorm Stress Feline2
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets. PANTOPRAZOLE SODIUM delayed-release tablets Initial U.S. approval: 20001
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TAllergy Composition3
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TMetformin Hydrochloride Extended - Release Tablets1
Sodium CarbonateINACTIVE INGREDIENT45P3261C7TPantoprazole Sodium Delayed-Release Tablets1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7T8459857e-1a52-45de-81e6-e06ce18508bb2
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3263
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPRAVASTATIN SODIUM TABLET [BRYANT RANCH PREPACK]1000
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) GRANULE, DELAYED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]26
Sodium CarbonateINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [JUBILANT CADISTA PHARMACEUTICALS INC.]18
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE SODIUM DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]15
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TMERREM IV (MEROPENEM) INJECTION [ASTRAZENECA PHARMACEUTICALS LP]14
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TTAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]14
sodium carbonateINACTIVE INGREDIENT45P3261C7TFUZEON (ENFUVIRTIDE) KIT [GENENTECH, INC.]13
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TNICORETTE WHITE ICE MINT (NICOTINE POLACRILEX) GUM, CHEWING NICORETTE ORIGINAL (NICOTINE POLACRILEX) GUM, CHEWING NICORETTE CINNAMON SURGE (NICOTINE POLACRILEX) GUM, CHEWING NICORETTE FRESH MINT (NICOTINE POLACRILEX) GUM, CHEWING NICORETTE MINT (NICOTINE POLACRILEX) GUM, CHEWING NICORETTE SPEARMINT BURST (NICOTINE POLACRILEX) GUM, CHEWING [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]13
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TTAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]13
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]12
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.]12
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]12
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [APOTEX CORP.]11
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [INTERNATIONAL LABORATORIES, INC.]11
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]11
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC]11

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 45P3261C7T page 1 of 1 · 28 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
SODIUM CARBONATE45P3261C7T497198GUM, CHEWINGBUCCAL720 mg
SODIUM CARBONATE45P3261C7T497198TABLETBUCCAL20 mg
SODIUM CARBONATE45P3261C7T497198INJECTIONINFILTRATIONADJ PH
SODIUM CARBONATE45P3261C7T497198INJECTION, SOLUTIONINTRA-ARTERIALADJ PH
SODIUM CARBONATE45P3261C7T497198INJECTIONINTRAMUSCULAR32.4 mg
SODIUM CARBONATE45P3261C7T497198INJECTION, POWDER, FOR SOLUTIONINTRAMUSCULAR630 mg
SODIUM CARBONATE45P3261C7T497198INJECTIONINTRAVASCULARADJ PH
SODIUM CARBONATE45P3261C7T497198INJECTION, SOLUTIONINTRAVASCULARADJ PH
SODIUM CARBONATE45P3261C7T497198INJECTIONINTRAVENOUS241 mg
SODIUM CARBONATE45P3261C7T497198INJECTION, POWDER, FOR SOLUTIONINTRAVENOUS1248 mg
SODIUM CARBONATE45P3261C7T497198INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRAVENOUS1247 mg
SODIUM CARBONATE45P3261C7T497198INJECTION, SOLUTIONINTRAVENOUSADJ PH
SODIUM CARBONATE45P3261C7T497198SOLUTIONOPHTHALMIC0.01 %w/v
SODIUM CARBONATE45P3261C7T497198CAPSULE, DELAYED RELEASEORAL90 mg
SODIUM CARBONATE45P3261C7T497198CAPSULE, EXTENDED RELEASEORAL6 mg
SODIUM CARBONATE45P3261C7T497198GRANULE, FOR SUSPENSIONORAL39 mg
SODIUM CARBONATE45P3261C7T497198GUM, CHEWINGORAL240 mg
SODIUM CARBONATE45P3261C7T497198LOZENGEORAL500 mg
SODIUM CARBONATE45P3261C7T497198SUSPENSIONORAL48 mg
SODIUM CARBONATE45P3261C7T497198TABLETORAL100 mg
SODIUM CARBONATE45P3261C7T497198TABLET, DELAYED RELEASEORAL90 mg
SODIUM CARBONATE45P3261C7T497198TABLET, EFFERVESCENTORAL430 mg
SODIUM CARBONATE45P3261C7T497198TABLET, EXTENDED RELEASEORAL80 mg
SODIUM CARBONATE45P3261C7T497198TABLET, FILM COATEDORAL30 mg
SODIUM CARBONATE45P3261C7T497198TROCHEORAL375 mg
SODIUM CARBONATE45P3261C7T497198INJECTIONSUBCUTANEOUSADJ PH
SODIUM CARBONATE45P3261C7T497198TABLETSUBLINGUAL8 mg
SODIUM CARBONATE45P3261C7T497198SOAPTOPICAL0.5 %w/w